FOI release

Ixazomib hard capsules (PLGB 15475/0059, PLGB 15475/0060 and PLGB 15475/0061)

This request was refused in full, so we didn't provide the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2026/00653

Received 18 June 2026

Published 12 August 2026

Request

Please can you kindly provide the finished product manufacturer(s) name(s) and address(s) as well as the Active Substance Manufacturer(s) details for: Ixazomib 2.5 mg, 3 mg and 4 mg hard capsules (previously called Ninlaro hard capsules) MA numbers: PLGB 15475/0059, PLGB 15475/0060 and PLGB 15475/0061 MAH: Takeda Pharma A/S, Delta Park 45, 2665 Vallensbaek Strand, Denmark

Response

See attached

Documents

• FOI2026_00653 (redacted).pdf (970.7 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.